Tata India Pharma & Healthcare Fund (IDCW)

EquitySectoral / Thematic

Last Updated NAV Date: 05 Jun 2026

3 Year Returns

21.75%

NAV (₹)

29.8866

1 Day NAV Change

0.26%

No chart data available for this period.

Fund Details

Min. SIP Amount₹ 100
Min. Lumpsum Amount₹ 5000
AUM₹ 1325.19 Cr
Expense Ratio2.08%
Lock-in PeriodNo Lock-in Period
Inception Date28 Dec 2015
Fund Age10 Yrs

Exit Load

0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.

Fund’s Investment Objective

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Calculate Your Mutual Fund Returns

Calculator

Returns Estimator

Estimation is based on the past performance

Expected Rate of Return

The value of your investment after 5 Years will be

4,12,432

Invested Amount

3,00,000

Est. Returns

1,12,432

Scheme’s Historical Return

1 Month Return1.51%
3 Month Return4.35%
6 Month Return1.30%
1 Year Return5.14%
3 Year Return21.75%
5 Year Return13.21%

Asset Allocation

AUM

₹1,33,309.00 Cr

Cash Holdings

21.45%

Equity

70.84%

Cash

21.45%

Debt

1.71%

Other

6%

Sector Holdings

Last Updated: 30 Apr 2026
SectorsAllocationWeightageValue (in Cr.)
Pharmaceuticals
58.95%781.172
Healthcare
35.17%466.051
Agro Chemicals
4.49%59.456
Chemicals
0.72%9.547
Insurance
0.68%8.961

Stock Holdings

Last Updated: 30 Apr 2026
NameAllocationWeightageValue (in Cr.)Sector
Sun Pharma.Inds.
9.87%130.764Pharmaceuticals
Divi's Lab.
5.92%78.42Pharmaceuticals
Health.Global
5.45%72.24Healthcare
Abbott India
5.37%71.099Pharmaceuticals
Max Healthcare
5.17%68.569Healthcare
Cipla
5.07%67.15Pharmaceuticals
Rainbow Child.
4.23%55.995Healthcare
Apollo Hospitals
4.06%53.825Healthcare
Dr Reddy's Labs
3.73%49.406Pharmaceuticals
Mankind Pharma
3.73%49.431Pharmaceuticals

Fund Manager Details

From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o BBA (Banking & Insurance), PGDM- IMT Ghaziabad

Risk-O-Meter

Very High Risk

Investors understand that their principal will be at Very High Risk

Risk Scale

Low
Moderately Low
Moderate
Moderately High
High
Very High

AMC Information

Tata Mutual Fund

Funds Managed

67

Assets Managed

₹ 2,30,219.64 Cr

Contact Details

www.tatamutualfund.com

Registered Address

1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051

Managing Director

Mr. Rajiv Sabharwal

Chief Executive Officer

Mr. Prathit D.Bhobe

Compliance Officer

Mr. Padmanabhan Ramanatha

No open NFOs available
Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

The Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund (IDCW) is updated at the end of every business day. You can check the latest NAV in the header section of this page.
You can invest in Tata India Pharma & Healthcare Fund (IDCW) online through the Anand Rathi AR Invest app or website. Simply log in, complete your KYC if not already done, and choose between SIP or Lumpsum investment modes.
Exit load varies by scheme. For Tata India Pharma & Healthcare Fund (IDCW), please refer to the "Fund Details" section above to see if any exit load applies for early redemptions.
Mutual funds are generally suitable for long-term wealth creation. However, suitability depends on your individual risk appetite and financial goals. You should review the riskometer and fund performance before investing.
Once you invest, you can track your portfolio performance, NAV changes, and transaction history in real-time through the AR Invest dashboard.

Download the AR Invest App

  • 5000+ Schemes
  • Personalized Solutions
  • Expert Insights
Download app from Google Play Store opens in a window
Download app from Apple App Store opens in a window